AstraZeneca appoints new president of US business

Mr Fante takes over from Tony Zook, whose role was expanded after recently being named president of MedImmune, the wholly owned biologics business of AstraZeneca. Mr Zook is CEO of AstraZeneca North America and head of global marketing.

Previously, Mr Fante served as AstraZeneca’s vice president of brand strategy and portfolio operations. Mr Fante led the development and execution of marketing strategies for all AstraZeneca brands in the US. Mr Fante holds a bachelor’s degree in biology from Princeton University and an MBA from the University of North Carolina.

Mr Zook said: “Rich brings strong leadership and a wealth of experience that is invaluable to our business and for improving patient health.”